Status:
COMPLETED
Exercise Pulmonary Transit Time
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Heart Failure, Diastolic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.
Detailed Description
The ability to measure the amount of blood in the lungs using heart-ultrasound (echocardiography) can be useful to estimate how much fluid is in a patient's circulation, which can influence diagnosis ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Able to give informed consent
Exclusion
- Known allergic reaction to Definity or Optison ultrasound contrast
- Pregnancy/Nursing - as assessed/disclosed by the participant
Key Trial Info
Start Date :
August 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04336995
Start Date
August 27 2020
End Date
March 1 2024
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VHVI
Nashville, Tennessee, United States, 37232